Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Expansion Therapy”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339176
What this trial is testing

Intratumoral N17350 in Advanced Solid Tumors

Who this might be right for
Neoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more
Onchilles Pharma Inc 275
Testing effectiveness (Phase 2)UnknownNCT05805956
What this trial is testing

IMM2902 in Patients With Advanced Solid Tumors Expressing HER2

Who this might be right for
Advanced Solid TumorAdvanced Lung CancerAdvanced Gastric Carcinoma+1 more
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 105
Early research (Phase 1)Ended earlyNCT04999202
What this trial is testing

Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults

Who this might be right for
Advanced Solid Tumors
Bayer 47
Early research (Phase 1)WithdrawnNCT05905341
What this trial is testing

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Who this might be right for
Breast CancerOvarian CancerLiposarcoma+3 more
Pfizer
Early research (Phase 1)Active Not RecruitingNCT02143466
What this trial is testing

AZD9291 in Combination With Ascending Doses of Novel Therapeutics

Who this might be right for
Advanced Non Small Cell Lung Cancer
AstraZeneca 344
Testing effectiveness (Phase 2)Study completedNCT02240238
What this trial is testing

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

Who this might be right for
Solid Tumors
NanoCarrier Co., Ltd. 119
Not applicableStudy completedNCT04790617
What this trial is testing

ENCOMPASS: Expansion Study B, RCT

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Chronic Kidney Diseases+4 more
University of Calgary 183
Early research (Phase 1)Ended earlyNCT02367352
What this trial is testing

Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsOvarian CancerSmall Cell Lung Cancer
Millennium Pharmaceuticals, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT03604692
What this trial is testing

Evaluate Axatilimab in Participants With Active cGVHD

Who this might be right for
Chronic Graft-versus-host-disease
Syndax Pharmaceuticals 41
Early research (Phase 1)Study completedNCT02411591
What this trial is testing

Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Eli Lilly and Company 66
Not applicableStudy completedNCT00245427
What this trial is testing

Outcomes of Patients Not Responding to Antibiotics in the Community

Who this might be right for
SinusitisBronchitis, ChronicPneumonia, Bacterial
CPL Associates 200
Not applicableStudy completedNCT02892773
What this trial is testing

Comparing the Effectiveness of Lung Expansion Therapy in Adult Human Subjects

Who this might be right for
Atelectasis
University of Virginia 112
Early research (Phase 1)Looking for participantsNCT04678648
What this trial is testing

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmRAS MutationLung Cancer+3 more
RasCal Therapeutics, Inc. 134
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+8 more
IDEAYA Biosciences 260
Early research (Phase 1)Study completedNCT04555213
What this trial is testing

A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19

Who this might be right for
Covid19
Noxopharm Limited 41
Early research (Phase 1)Study completedNCT03270176
What this trial is testing

A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasms
Debiopharm International SA 54
Early research (Phase 1)Looking for participantsNCT04503278
What this trial is testing

A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

Who this might be right for
Solid Tumor
BioNTech Cell & Gene Therapies GmbH 214
Early research (Phase 1)Study completedNCT03099174
What this trial is testing

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

Who this might be right for
NeoplasmsBreast Neoplasms
Boehringer Ingelheim 133
Testing effectiveness (Phase 2)Looking for participantsNCT04977453
What this trial is testing

GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancer+11 more
GI Innovation, Inc. 430
Testing effectiveness (Phase 2)Active Not RecruitingNCT03830918
What this trial is testing

Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy

Who this might be right for
Advanced Malignant Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more
Jonsson Comprehensive Cancer Center 59
Load More Results